AI Articles and Analysis in Pharma

Far beyond surface-level 'chatbot' software, and other customer-facing support systems, the same generative AI (GenAI) capabilities having direct impacts across language workflows in front-office tasks in financial and legal services is also having a direct impact on how research teams in the life sciences space are targeting solutions for rare diseases and novel treatments. 

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

Dell Technologies Inc., or simply 'Dell', is a Texas-based multinational technology company. Dell is predominantly known for its personal computing products, particularly its desktops, laptops, and workstations. Gradually, the company branched out into other product and service offerings, including network equipment, software and cloud solutions, and automation services.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Quantiphi and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

AI and data science have seen increased use in life sciences, particularly in the pharmaceutical industry. However, despite the multitude of AI use cases, pharmaceutical companies tend not to embrace every emerging AI trend eagerly. 

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.